A detailed history of Pictet Asset Management Holding Sa transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,378,036 shares of VKTX stock, worth $73 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,378,036
Previous 694,724 98.36%
Holding current value
$73 Million
Previous $12.9 Million 774.06%
% of portfolio
0.13%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$17.4 - $94.5 $11.9 Million - $64.6 Million
683,312 Added 98.36%
1,378,036 $113 Million
Q4 2023

Feb 13, 2024

BUY
$9.24 - $19.64 $6.31 Million - $13.4 Million
683,355 Added 6010.69%
694,724 $12.9 Million
Q3 2023

Nov 14, 2023

BUY
$10.92 - $16.0 $124,149 - $181,904
11,369 New
11,369 $125,000

Others Institutions Holding VKTX

About Viking Therapeutics, Inc.


  • Ticker VKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,688,496
  • Market Cap $4.07B
  • Description
  • Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...
More about VKTX
Track This Portfolio

Track Pictet Asset Management Holding Sa Portfolio

Follow Pictet Asset Management Holding Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Holding Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Holding Sa with notifications on news.